Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
about
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica.Human Microbiome: When a Friend Becomes an EnemyFirst-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasisInterleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis.Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway.IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generationCytokine-modulating strategies and newer cytokine targets for arthritis therapy.The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activationChemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontinThe microbiome and rheumatoid arthritisPharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model.cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesIntegrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcomeCollagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid ArthritisThe Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary CirrhosisInterleukin-17: a promoter in colorectal cancer progressionOsteoimmunology and Beyond.Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis.Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis.Deciphering the role of Th17 cells in human disease.Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?The pathologic and clinical intersection of atopic and autoimmune disease.Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis.Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.Functional plasticity of Th17 cells: implications in gastrointestinal tract function.Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity.Role of Th17 Cells in the Pathogenesis of Human IBD.Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesAltered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practiceIL-17 and IL-22 in immunity: Driving protection and pathology.Interleukin 17 is a chief orchestrator of immunity.A Truncated IL-17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice.Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.
P2860
Q24336199-38BBD9E7-C403-4B0F-A1AB-497507AED312Q26744656-E82A4E73-90C9-44F8-8B17-9AB99675075EQ28085629-BA53AE84-E657-4C45-BF62-33C9320958C6Q33593625-FBE2490D-27B6-466B-AB55-830A13F20913Q34065372-5E621855-AE7B-4417-B374-C2ABA04E3604Q34405961-FFF1CF35-7C06-41B5-B5CB-84C62A99F9C6Q34440569-6F219B55-5F02-4DC1-8F88-35AA207F70B8Q34456715-E8DE6374-0CEA-4287-8DD1-FB9E98DFBFA1Q34544926-15E672FC-64FC-40EB-817F-87333EC6692FQ34591831-E28ADD70-4BE1-4E75-96FB-D0707AC8BEA8Q34745567-48772737-EDC4-458D-A6F2-02A5ACA10B8BQ35743863-5AC5643D-B4B7-4F61-8021-555566B4FBADQ35760186-13B12DC1-97CF-4634-AE3F-CAC2530A9096Q35763036-CA87EF9A-95C8-4907-B5BC-D738CF3C725DQ36249305-FDF75BB9-7213-43DE-99D8-B4D7B44623E1Q36367126-AD027318-C543-450E-8ED0-C14DB3BB337CQ36437722-92CE222E-8F7C-4318-B9E0-1E9693407EF3Q37026138-A810B2F6-511E-4C73-818A-F82E6E164E4FQ37409208-7683E771-8E22-497B-B285-49B7E24FB480Q37548012-956559E5-03A2-445C-9C86-ABE9A0EF81BCQ37597083-0D282B84-AC16-40FF-96FA-233017BC2CFFQ37690610-2D639206-5444-4821-9548-E61EE0B553C4Q37940695-D4EE809A-3F77-4B12-BDFF-86D5F25B03CFQ37979842-D64951B9-B9D6-41EB-80E8-AC7608AE0FF3Q38016854-EE21EB58-73B5-4CC7-BFD6-B12AEDA18EF7Q38035182-1E388B32-793A-4698-AB55-BEF62C1469ABQ38078271-797170A5-13E0-413D-92A7-C33805ACDB67Q38118781-455215CC-CFE6-4252-9391-1F2B45D5FA77Q38138105-C66E2B60-3A45-4AD8-B851-C812B9DB8DF9Q38144077-8BF4F360-ACAE-4170-80CD-21EC776AB634Q38237647-48D72BB8-F97F-4127-BDF1-572D2BCF1ABCQ38543052-79226B78-3426-4C31-8898-480B0EB3AA8AQ38960509-A1F85BE5-DF34-4A39-842F-2DC73C46960AQ39080325-4BF16326-B95C-495A-B4F6-779849D0B599Q39153776-CF6175C5-A867-4AF0-B6EA-E3D05F453A04Q39179415-9D660961-AA52-4B47-9643-41523C50786CQ39314776-2E535DD6-E88F-42A8-9F08-E25413872F92Q39317301-5A886587-CFF5-4992-86C3-7AF5E8DA9AC0Q39350335-57DF7842-29C2-47EA-8EFF-62B192948095Q40695075-CF22423C-C355-4340-AED9-4C1676C05E9B
P2860
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
@en
Effects of interleukin
@nl
type
label
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
@en
Effects of interleukin
@nl
prefLabel
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
@en
Effects of interleukin
@nl
P356
P1476
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
@en
P2093
Arnaud Hot
P304
P356
10.1136/ARD.2010.143768
P407
P577
2011-02-22T00:00:00Z